Hormone receptors and human epidermal growth factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma – Role in patient management | Zendy

Kusum Kapila | Zendy; I. Francis | Zendy; Rabeah AlTemaimi | Zendy; Bushra AlAyadhy | Zendy; Preeta Alath | Zendy; Mohammed Jaragh | Zendy; FatmaJasem Mothafar | Zendy

Open Access

Hormone receptors and human epidermal growth factor (HER2) expression in fine-needle aspirates from metastatic breast carcinoma – Role in patient management

Author(s) -

Kusum Kapila,

I. Francis,

Rabeah AlTemaimi,

Bushra AlAyadhy,

Preeta Alath,

Mohammed Jaragh,

FatmaJasem Mothafar

Publication year - 2019

Publication title -

journal of cytology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.267

H-Index - 19

eISSN - 0974-5165

pISSN - 0970-9371

DOI - 10.4103/joc.joc_117_18

Subject(s) - medicine , human epidermal growth factor receptor 2 , metastatic breast cancer , hormone , breast carcinoma , epidermal growth factor , hormone receptor , receptor , oncology , cancer research , breast cancer , cancer

Estrogen receptors (ER), progesterone receptors (PR), and epidermal growth factor (HER2) are prognostic and predictive factors for breast carcinoma. We determined them by immunohistochemistry (IHC) on cell blocks from fine-needle aspirates (FNA) of metastatic breast carcinoma to axillary lymphnodes and compared them with that reported in the primary breast carcinoma (PBC) to document any change in their expression for future management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research